S
Steve D. Groshong
Researcher at University of Colorado Denver
Publications - 70
Citations - 7122
Steve D. Groshong is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Lung & Idiopathic pulmonary fibrosis. The author has an hindex of 32, co-authored 63 publications receiving 5827 citations. Previous affiliations of Steve D. Groshong include National Jewish Health & Colorado School of Mines.
Papers
More filters
Journal ArticleDOI
An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals
Gustavo Matute-Bello,Gregory P. Downey,Bethany B. Moore,Steve D. Groshong,Michael A. Matthay,Arthur S. Slutsky,Wolfgang M. Kuebler +6 more
TL;DR: This list of features and measurements of ALI is intended as a guide for investigators, and ultimately investigators should choose the particular measurements that best suit the experimental questions being addressed as well as take into consideration any unique aspects of the experimental design.
Journal ArticleDOI
A common MUC5B promoter polymorphism and pulmonary fibrosis
Max A. Seibold,Anastasia L. Wise,Marcy C. Speer,Mark P. Steele,Kevin K. Brown,James E. Loyd,Tasha E. Fingerlin,Weiming Zhang,Gunnar Gudmundsson,Steve D. Groshong,Christopher M. Evans,Stavros Garantziotis,Kenneth B. Adler,Burton F. Dickey,Roland M. du Bois,Ivana V. Yang,Aretha Herron,Dolly Kervitsky,Janet Talbert,Cheryl Markin,Joungjoa Park,Anne L. Crews,Susan Slifer,Scott S. Auerbach,Michelle G. Roy,Jia Lin,Corinne E. Hennessy,Marvin I. Schwarz,David A. Schwartz +28 more
TL;DR: The findings suggest that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis, and a common polymorphism in the promoter of M UC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrot.
Journal ArticleDOI
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
Tasha E. Fingerlin,Elissa Murphy,Weiming Zhang,Anna L. Peljto,Kevin K. Brown,Mark P. Steele,James E. Loyd,Gregory P. Cosgrove,David A. Lynch,Steve D. Groshong,Harold R. Collard,Paul J. Wolters,Williamson Z. Bradford,Karl Kossen,Scott D. Seiwert,Roland M. du Bois,Christine Kim Garcia,Megan S. Devine,Gunnar Gudmundsson,Helgi J Isaksson,Naftali Kaminski,Yingze Zhang,Kevin F. Gibson,Lisa Lancaster,Joy D. Cogan,Wendi R. Mason,Toby M. Maher,Philip L. Molyneaux,Athol U. Wells,Miriam F. Moffatt,Moisés Selman,Annie Pardo,Dong Soon Kim,James D. Crapo,Barry J. Make,Elizabeth A. Regan,Dinesha Walek,Jerry Daniel,Yoichiro Kamatani,Diana Zelenika,Keith P Smith,David McKean,Brent S. Pedersen,Janet Talbert,Ravin N. Kidd,Cheryl Markin,Kenneth B. Beckman,Mark Lathrop,Mark Lathrop,Marvin I. Schwarz,David A. Schwartz +50 more
TL;DR: The results suggest that genes involved in host defense, cell-cell adhesion and DNA repair contribute to risk of fibrotic IIPs.
Journal ArticleDOI
Modern age pathology of pulmonary arterial hypertension.
Elvira Stacher,Brian B. Graham,James M. Hunt,Aneta Gandjeva,Steve D. Groshong,Vallerie V. McLaughlin,Marsha Jessup,William E. Grizzle,Michaela A. Aldred,Carlyne D. Cool,Rubin M. Tuder +10 more
TL;DR: The results indicate that multiple features of pulmonary vascular remodeling are present in patients treated with modern PAH therapies, and perivascular inflammation may have an important role in the processes ofascular remodeling, all of which may ultimately lead to increased pulmonary artery pressure.
Journal ArticleDOI
Biphasic Regulation of Breast Cancer Cell Growth by Progesterone: Role of the Cyclin-Dependent Kinase Inhibitors, p21 and p27Kip1
Steve D. Groshong,Gareth I. Owen,Bryn Grimison,Irene E. Schauer,Maria C. Todd,Thomas A. Langan,Robert A. Sclafani,Carol A. Lange,Kathryn B. Horwitz +8 more
TL;DR: It is concluded that progesterone is neither inherently proliferative nor antiproliferative, but that it is capable of stimulating or inhibiting cell growth depending on whether treatment is transient or continuous.